Search Results 351-360 of 16838 for Chlorpromazine

  1. Clotrimazole (topical route) - Side effects & dosage - Mayo Clinic

    This medicine is available both over-the-counter (OTC) and with your doctor's prescription. This product is available in the following dosage forms: Cream ...

  2. A Study To Evaluate The Long-term Safety And Tolerability Of Inhaled LIQ861(Treprostinil) In Pulmonary Arterial Hypertension Patients - Mayo Clinic

    A secondary objective of this study is to evaluate the comparative bioavailability of treprostinil between two formulations of inhaled therapy. Participation ...

  3. Raxibacumab (intravenous route) - Side effects & uses - Mayo Clinic

    Raxibacumab injection is given with antibiotic medicines to treat inhalational anthrax. It is also used to prevent inhalational anthrax when there are no other ...

  4. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  5. Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis. - Mayo Clinic

    Inclusion Criteria: 1. Patients 18 - 85 years of age 2. Two or more documented attacks of acute pancreatitis, separated by 3 months from one another, ...

  6. Brexpiprazole (oral route) - Side effects & dosage - Mayo Clinic

    This medicine should not be used to treat behavioral problems in elderly patients who have dementia. Breastfeeding. There are no adequate studies in women for ...

  7. https://www.mayoclinic.org/spanish_organization_concepts.xml

  8. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

    The purpose of this study is to evaluate whether CRS-207 with pembrolizumab is safe and effective in adults with MPM who have failed prior anti-cancer therapy.

  9. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  10. Measuring If Immunotherapy Plus Chemotherapy Is Better Than Chemotherapy Alone For Patients With Aggressive Poorly Differentiated Sarcomas - Mayo Clinic

    The purpose of this study is to assess whether the combination of doxorubicin and pembrolizumab will improve progression free survival (PFS) in UPS and related ...